Omnipod DASH Insulin Management System, Product Catalog Number 18239 M/D: PDM USA1 D001 MG USA1

FDA Device Recall #Z-0347-2020 — Class II — December 18, 2018

Recall Summary

Recall Number Z-0347-2020
Classification Class II — Moderate risk
Date Initiated December 18, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Insulet Corporation
Location Billerica, MA
Product Type Devices
Quantity 264

Product Description

Omnipod DASH Insulin Management System, Product Catalog Number 18239 M/D: PDM USA1 D001 MG USA1

Reason for Recall

There is a potential for a communication interruption following a bolus command that may result in inaccurate information presented in insulin on board (IOB), last bolus field or bolus history.

Distribution Pattern

US Nationwide.

Lot / Code Information

Lot Numbers L000120, L000121, L000122, L000123, L000124, L000131, L000132, L000133, L000135, L000136

Other Recalls from Insulet Corporation

Recall # Classification Product Date
Z-1797-2026 Class I Omnipod 5 Pods. Model/Catalog number: PT-001662... Mar 12, 2026
Z-0132-2026 Class II The failure occurs if a user on the Omnipod 5 i... Sep 11, 2025
Z-2016-2025 Class II Omnipod 5 Automated Insulin Delivery System, iO... May 23, 2025
Z-0591-2024 Class I Omnipod 5 App (on compatible Android smartphone... Nov 30, 2023
Z-2618-2023 Class II Omnipod 5 Automated Insulin Delivery System Feb 28, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.